Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
PLoS Med
    September 2021
  1. FIGUEROA JP, Hotez PJ, Batista C, Ben Amor Y, et al
    Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
    PLoS Med. 2021;18:e1003772.
    >> Share

  2. KROGSGAARD LW, Petersen I, Plana-Ripoll O, Bech BH, et al
    Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis.
    PLoS Med. 2021;18:e1003768.
    >> Share

    August 2021
  3. CHAN J, Gidding HF, Blyth CC, Fathima P, et al
    Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.
    PLoS Med. 2021;18:e1003733.
    >> Share

  4. ISANAKA S, Garba S, Plikaytis B, Malone McNeal M, et al
    Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial.
    PLoS Med. 2021;18:e1003720.
    >> Share

  5. BINES JE
    Investigating barriers to the protective efficacy provided by rotavirus vaccines in African infants.
    PLoS Med. 2021;18:e1003721.
    >> Share

    July 2021
  6. ISANAKA S, Langendorf C, McNeal MM, Meyer N, et al
    Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.
    PLoS Med. 2021;18:e1003655.
    >> Share

    June 2021
  7. GRAY P, Kann H, Pimenoff VN, Eriksson T, et al
    Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
    PLoS Med. 2021;18:e1003588.
    >> Share

  8. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
    Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
    PLoS Med. 2021;18:e1003675.
    >> Share

    May 2021
  9. GOLDMAN M, Hermans C
    Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
    PLoS Med. 2021;18:e1003648.
    >> Share

    April 2021
  10. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    >> Share

    March 2021
  11. KIM JJ, Simms KT, Killen J, Smith MA, et al
    Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003534.
    >> Share

    February 2021
  12. JEAN K, Raad H, Gaythorpe KAM, Hamlet A, et al
    Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study.
    PLoS Med. 2021;18:e1003523.
    >> Share

  13. KLEYNHANS J, Tempia S, Shioda K, von Gottberg A, et al
    Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study.
    PLoS Med. 2021;18:e1003537.
    >> Share

    November 2020
  14. HOGAN AB, Winskill P, Ghani AC
    Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    PLoS Med. 2020;17:e1003377.
    >> Share

    October 2020
  15. LAWRENCE H, Pick H, Baskaran V, Daniel P, et al
    Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.
    PLoS Med. 2020;17:e1003326.
    >> Share

  16. BAUMGAERTNER B, Ridenhour BJ, Justwan F, Carlisle JE, et al
    Risk of disease and willingness to vaccinate in the United States: A population-based survey.
    PLoS Med. 2020;17:e1003354.
    >> Share

    September 2020
  17. STOWE J, Andrews N, Gringras P, Quinnell T, et al
    Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    PLoS Med. 2020;17:e1003225.
    >> Share

    August 2020
  18. BENJAMIN-CHUNG J, Arnold BF, Kennedy CJ, Mishra K, et al
    Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study.
    PLoS Med. 2020;17:e1003238.
    >> Share

    July 2020
  19. SAVICKAS V, Stewart AJ, Rees-Roberts M, Short V, et al
    Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
    PLoS Med. 2020;17:e1003197.
    >> Share

    May 2020
  20. MOODIE Z, Walsh SR, Laher F, Maganga L, et al
    Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
    PLoS Med. 2020;17:e1003117.
    >> Share

    April 2020
  21. MCNAUGHTON AL, Lourenco J, Bester PA, Mokaya J, et al
    Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003068.
    >> Share

    March 2020
  22. MORRISON M, Castro LA, Ancel Meyers L
    Conscientious vaccination exemptions in kindergarten to eighth-grade children across Texas schools from 2012 to 2018: A regression analysis.
    PLoS Med. 2020;17:e1003049.
    >> Share

  23. FORSTER AH, Witham K, Depelsenaire ACI, Veitch M, et al
    Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    PLoS Med. 2020;17:e1003024.
    >> Share

  24. FELDSTEIN LR, Bennett SD, Estivariz CF, Cooley GM, et al
    Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
    PLoS Med. 2020;17:e1003071.
    >> Share

  25. ESTIVARIZ CF, Bennett SD, Lickness JS, Feldstein LR, et al
    Assessment of immunity to polio among Rohingya children in Cox's Bazar, Bangladesh, 2018: A cross-sectional survey.
    PLoS Med. 2020;17:e1003070.
    >> Share

    February 2020
  26. LAHER F, Moodie Z, Cohen KW, Grunenberg N, et al
    Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    PLoS Med. 2020;17:e1003038.
    >> Share

    January 2020
  27. SUNDSTROM K, Elfstrom KM
    Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
    PLoS Med. 2020;17:e1003035.
    >> Share

    December 2019
  28. LEE EC, Azman AS, Kaminsky J, Moore SM, et al
    The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study.
    PLoS Med. 2019;16:e1003003.
    >> Share

  29. BAKER JM, Tate JE, Leon J, Haber MJ, et al
    Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
    PLoS Med. 2019;16:e1003005.
    >> Share

  30. NYATHI S, Karpel HC, Sainani KL, Maldonado Y, et al
    The 2016 California policy to eliminate nonmedical vaccine exemptions and changes in vaccine coverage: An empirical policy analysis.
    PLoS Med. 2019;16:e1002994.
    >> Share

    August 2019
  31. OKALA SG, Darboe MK, Sosseh F, Sonko B, et al
    Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia.
    PLoS Med. 2019;16:e1002854.
    >> Share

    July 2019
  32. CHOI YH, Andrews N, Miller E
    Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
    PLoS Med. 2019;16:e1002845.
    >> Share

  33. BAKER MA, Baer B, Kulldorff M, Zichittella L, et al
    Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results.
    PLoS Med. 2019;16:e1002844.
    >> Share

    April 2019
  34. VEKEMANS J, O'Brien KL, Farrar J
    Tuberculosis vaccines: Rising opportunities.
    PLoS Med. 2019;16:e1002791.
    >> Share

  35. MANJALY THOMAS ZR, Satti I, Marshall JL, Harris SA, et al
    Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
    PLoS Med. 2019;16:e1002790.
    >> Share

    March 2019
  36. TURNER R
    Measles vaccination: A matter of confidence and commitment.
    PLoS Med. 2019;16:e1002770.
    >> Share

  37. BOGAARDS JA, Mooij SH, Xiridou M, Schim van der Loeff MF, et al
    Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.
    PLoS Med. 2019;16:e1002756.
    >> Share

    August 2018
  38. KAHN R, Rid A, Smith PG, Eyal N, et al
    Choices in vaccine trial design in epidemics of emerging infections.
    PLoS Med. 2018;15:e1002632.
    >> Share

    March 2018
  39. POWELL-JACKSON T, Fabbri C, Dutt V, Tougher S, et al
    Effect and cost-effectiveness of educating mothers about childhood DPT vaccination on immunisation uptake, knowledge, and perceptions in Uttar Pradesh, India: A randomised controlled trial.
    PLoS Med. 2018;15:e1002519.
    >> Share

    February 2018
  40. FINGER F, Bertuzzo E, Luquero FJ, Naibei N, et al
    The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.
    PLoS Med. 2018;15:e1002509.
    >> Share

  41. VON SEIDLEIN L, Deen JL
    Preventing cholera outbreaks through early targeted interventions.
    PLoS Med. 2018;15:e1002510.
    >> Share

    January 2018
  42. YAESOUBI R, Trotter C, Colijn C, Yaesoubi M, et al
    The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study.
    PLoS Med. 2018;15:e1002495.
    >> Share

  43. SRINIVASAN P, Wu X, Basu M, Rossi C, et al
    PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.
    PLoS Med. 2018;15:e1002497.
    >> Share

    November 2017

  44. malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002455.
    >> Share

    October 2017
  45. AGNANDJI ST, Fernandes JF, Bache EB, Obiang Mba RM, et al
    Safety and immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine in adults and children in Lambarene, Gabon: A phase I randomised trial.
    PLoS Med. 2017;14:e1002402.
    >> Share

    September 2017
  46. CANFELL K, Caruana M, Gebski V, Darlington-Brown J, et al
    Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    PLoS Med. 2017;14:e1002388.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016